MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20243322

March 12, 2024

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.3%(5ml:15mg)

化学药品

March 12, 2024

Company Information

Applicant Company

上海市松江工业区洞泾路5号

Manufacturing Company

北京市通州区靓丽五街3号院7号楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath